Search results
Results from the WOW.Com Content Network
Endometrial hyperplasia is a condition of excessive proliferation of the cells of the endometrium, or inner lining of the uterus. Most cases of endometrial hyperplasia result from high levels of estrogens , combined with insufficient levels of the progesterone-like hormones which ordinarily counteract estrogen's proliferative effects on this ...
Dydrogesterone, sold under the brand name Duphaston among others, [1] is a progestin medication which is used for a variety of indications, including threatened or recurrent miscarriage during pregnancy, dysfunctional bleeding, infertility due to luteal insufficiency, dysmenorrhea, endometriosis, secondary amenorrhea, irregular cycles, premenstrual syndrome, and as a component of menopausal ...
Metropathia haemorrhagica, also known as metropathia haemorrhagica cystica, is a menstrual disorder which is defined as a specialized type of anovulatory dysfunctional uterine bleeding associated with endometrial hyperplasia and intermenstrual bleeding.
Uterine hyperplasia, or enlarged uterus, is a medical symptom in which the volume and size of the uterus in a female is abnormally high. It can be a symptom of medical conditions such as adenomyosis , uterine fibroids , ovarian cysts , and endometrial cancer .
They are a subset of a larger mixed group of lesions previously called "endometrial hyperplasia". [ 2 ] [ 3 ] The EIN diagnostic schema is intended to replace the previous " endometrial hyperplasia " classification as defined by the World Health Organization in 1994, which have been separated into benign (benign endometrial hyperplasia) and ...
Endometrial resection is also limited to relatively shallow adenomyosis as significant bleeding may result from damage to large arteries that are present 5 mm deep within the myometrium. [ 6 ] Non-hysteroscopic procedures: These techniques do not require a hysteroscope , are relatively fast, and many can be performed as an outpatient procedure.
Megestrol acetate was reported to be effective in the treatment of endometrial hyperplasia in the mid-1960s. [6] It first started to be studied as a treatment for endometrial cancer in 1967, with findings published in 1973. [6] [156] [157] Megestrol acetate was reportedly introduced for the treatment of endometrial cancer in the United States ...
(E): endometrial atypical hyperplasia (Left: HE × 10) and endometrial atypical cells (Right: HE × 200) (F) endometrial carcinoma (Left: HE × 400) and endometrial cancer cells (Right: HE × 400). Chorionic tissue can result in marked endometrial changes, known as an Arias-Stella reaction, that have an appearance similar to cancer. [15]